<DOC>
	<DOCNO>NCT01136785</DOCNO>
	<brief_summary>The overall goal propose protocol rigorously test hypothesis CPAP treatment beneficial effect glycemic control patient type 2 diabetes ( T2DM ) obstructive sleep apnea ( OSA ) . If hypothesis proven , would imply CPAP treatment OSA patient T2DM essential component glycemic control . The proposed work thus expect provide additional preventive therapeutic approach management million patient T2DM .</brief_summary>
	<brief_title>Effects Continuous Positive Airway Pressure ( CPAP ) Treatment Glucose Control Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Male female subject type 2 diabetes stable medication regimen ( change diabetic medication previous 3 month ) eligible . Subjects insulin exclude . Subjects unstable cardiopulmonary disease , painful neuropathy , significant psychiatric illness , cognitive impairment pregnancy exclude . Shift worker Subjects travel across &gt; 2 time zone less one month prior study Diagnosis sleep disorder OSA screen polysomnography Previous treatment positive airway pressure supplemental oxygen Requirement supplemental oxygen bilevel positive airway pressure OSA treatment titration Claustrophobia condition CPAP intolerance , Presence active infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>